Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Acute porphyria

With observations on liver lesions and on porphobilinogenuria

Summary

  1. 1.

    Four cases of acute porphyria in female patients are recorded. The acute episodes were precipitated or made worse by the administration of barbiturates in all. Death occurred in the two patients showing the most marked neurological manifestations. The post-mortem of one of them is described. The clinical and pathological features of the cases are discussed.

  2. 2.

    Liver changes in acute porphyria are considered in detail and the literature reviewed. Functional and structural alterations are generally slight in this condition in distinction to porphyria cutanea tarda, but alterations in albumin/globulin ratio and in flocculation tests are not uncommon. A peculiar fine nodularity of the liver was observed on two occasions; this has been noted by others.

  3. 3.

    Serial determinations of porphobilinogen in the urine in one case showed a diminution in excretion as the patient’s clinical state improved. Porphobilinogen estimations are related to the underlying biochemical defect and are of much greater importance than estimations of uroporphyrin. The specificity of porphobilinogenuria is discussed.

  4. 4.

    The onset of an attack may be insidious, and the Watson-Schwartz test for porphobilinogen is of the utmost value in making the diagnosis early and in identifying susceptibles.

  5. 5.

    No sharp distinction can be drawn between cases with and without neurological manifestations and although those with the worst neurological signs generally die, some severely affected patients recover.

This is a preview of subscription content, log in to check access.

References

  1. Abbott, K. M., and Evans, M. S. (1946).Bull. Los Angeles Neurol. Soc., 11, 20.

  2. Berg, M. (1945).Arch. Int. Med., 76, 335.

  3. Borst, M. and Konigsdörffer, H. Jnr. (1929).Untersuchungen über Porphyrie, Leipzig.

  4. Cookson, G. H., and Rimington, C. (1954).Biochem. J., 57, 476.

  5. Correll, H. L., Peters, B. J., and Murphy, F. D. (1942).Urol. Cut. Rev., 46, 341.

  6. Davies, D. (1949).Brit. Med. J., i, 846.

  7. Dean, G., and Barnes, H. D. (1955).Ibid., ii, 89.

  8. Denny-Brown, D., and Sciarra, D. (1945).Brain, 68, 1.

  9. Discombe, G., and D’Silva, J. L. (1945).Brit. Med. J., ii, 491.

  10. Drury, R. A. B. (1956).J. Path. Bact. 71, 511.

  11. Eichler, P. (1932).Zts. ges. Neurol. Psychiat. 141, 363.

  12. Freedman, A. L. (1956).Ann. Int. Med. 44, 391.

  13. Gibson, J. B., and Goldberg, A. (1956).J. Path. Bact. 71, 495.

  14. Gibson, Q. H., Harrison, D. C., and Montgomery, D. A. D. (1950).Brit. Med. J., i, 275.

  15. Gilbert, J. A. L., Toupin, H. M., and Bell, R. E. (1951).Canad. Med. Ass. J., 65, 585.

  16. Goldberg, A. (1954 a)Biochem. J., 57, 55.

  17. — (1954 b) InThe Chemical Pathology of Animal Pigments, Biochem. Soc. Symposia No. 12, Cambridge, p. 27.

  18. — (1954 c)Lancet, ii, 1095.

  19. -(1956) Personal communication.

  20. — Macdonald, A. C., and Rimington, C. (1952).Brit. Med. J., ii, 1174.

  21. — Paton, W. D. M., and Thompson, J. W. (1954).Brit. J. Pharmacol. 9, 91.

  22. — and Rimington, C. (1955).Proc. Roy. Soc. B. 143, 257.

  23. Gray, G. M. (1950).Arch. Int. Med., 85, 459.

  24. Grogg, E. (1951).Schweiz. Archiv. Neurol. Psychiat. 67, 292.

  25. Hammond, R. L., and Welcker, M. L. (1948).J. Lab. Clin. Med., 33, 1254.

  26. Kernohan, R. J., and Perry, J. (1954).Ulster Med. J., 23, 63.

  27. Kezdi, P. (1954).Arch. Int. Med. 94, 122.

  28. Little, N., and Palmer, H. (1948).N. Z. Med. J., 47, 461.

  29. Lyons, H. A. (1950).Ann. Int. Med. 33, 711.

  30. McCaughey, W. T. E., and Millar, J. H. D. (1955).Lancet, ii, 365.

  31. Markovitz, M. (1954).Ann. Int. Med. 41, 1170.

  32. Mason, V. R., Courville, C., and Ziskind, E. (1933).Medicine, 12, 355.

  33. Mauzerall, D., and Granick, S. (1956).J. Biol. Chem., 219, 435.

  34. Nesbitt, S., and Watkins, C. H. (1942).Amer. J. Med. Sci., 203, 74.

  35. Popper, H. (1937).Virchows Arch., 298, 574.

  36. Prunty, F. T. G. (1946).Arch. Int. Med., 77, 625.

  37. -(1952). Personal communication to D. W. Neill.

  38. Bimington, C. (1955). InModern Trends in Blood Diseases, ed. J. F. Wilkinson, London, p. 147.

  39. — and Flynn, F. V. (1956).Brit. Med. J., i, 231.

  40. Schmid, R., and Schwartz, S. (1952).Proc. Soc. Exper. Biol. 81, 685.

  41. — Schwartz, S., and Watson, C. J. (1954).Arch. Int. Med., 93, 167.

  42. Schwarz, G. A., and Moulton, J. A. L. (1954).Ibid., 94, 221.

  43. Sunderman, F. W., Jr., and Sunderman, F. W. (1955).Amer. J. Clin. Path., 25, 1231.

  44. Vannotti, A. (1954).Porphyrins their Biological and Chemical Importance, trans. C. Rimington, London, pp. 181, 187, 207 and 211.

  45. Waldenstrom, J. (1934).Acta Med. Scand., 83, 281.

  46. — (1937).Ibid. Suppl. 82, pp. 69, 79, 81, 89 and 132.

  47. — and Vahlquist, B. (1944).Acta Med. Scand., 117, 1.

  48. Watson, C. J. (1954).Arch. Int. Med., 93, 643.

  49. — Lowry, P. T.,et al. (1951).Trans. Ass. Amer. Physic. 64, 345.

  50. — and Schwartz, S. (1941).Proc. Soc. Exp. Biol., 47, 393.

  51. Wehrmacher, W. H. (1952).Arch. Int. Med. 89, 111.

  52. Whittaker, S. R. F., and Whitehead, T. P. (1956).Lancet, i, 547.

Download references

Author information

Correspondence to J. B. Gibson or W. E. Parkes or C. F. Brennan.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Gibson, J.B., Parkes, W.E. & Brennan, C.F. Acute porphyria. Ir J Med Sci 32, 127 (1957). https://doi.org/10.1007/BF02952261

Download citation